Riverside University Health System Medical Center

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Riverside University Health System Medical Center sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials 2 currently recruiting 3 completed upper quartile by trial count

Riverside University Health System Medical Center: 7 sponsored US clinical trials, 2 recruiting.

Riverside University Health System Medical Center sponsors 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 3 completed. 1 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Vancomycin Resistant Enterococci Infection, with 1 trials.

Upper-quartile sponsor footprint

Riverside University Health System Medical Center sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Open and recent trials

7 total, page 1 of 1

RECRUITING NA

Steri-Strip Application Versus Standard Wound Closure for Cesarean Section Incisions

NCT07686913
RECRUITING Phase 2

Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients

NCT07221370
COMPLETED

Exogenous Sex Hormones and PONV

NCT06816355
COMPLETED

Is Continuous Non-Invasive Monitoring Accurate When Used on the Lower Extremity: Finger Vs Toe?

NCT06805435
NOT YET RECRUITING NA

Low Pressure Pneumoperitoneum Using AirSeal® for Reduction in Postoperative Shoulder Pain Following Robot Assisted Hiatal Hernia Repair

NCT06737068
COMPLETED NA

Real-Time CAD for Colonic Neoplasia: A RCT

NCT05963724
TERMINATED Phase 4

Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting

NCT02189395

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 4 1

Therapeutic Areas

Vancomycin Resistant Enterococci Infection 1
Clostridium Difficile Infection 1

What is open in the Riverside University Health System Medical Center pipeline

2 recruiting of 7 indexed (29% open); 3 completed (43%).

Phase mix: 1 late (III/IV) vs 1 early (I/II) (balanced across stages).

Top condition: Vancomycin Resistant Enterococci Infection (1 trial), 1 other listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Riverside University Health System Medical Center: open-pipeline peers nationwide

Peers matched on 7 registered trials and 29% open enrollment, not the therapeutic-area sidebar.

Riverside University Health System Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0102030405060 0%10%20%30%40% Total trials Recruiting share Riverside University Health System Medical Center3M4Life Research89bioAbbott Diagnostics DivisionAlabama Physical Therapy & AcupunctureAlloSourceAlnylam PharmaceuticalsAnnovis Bio
Riverside University Health System Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Riverside University Health System Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 trials (± recruiting share)

Sponsors near 29% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Riverside University Health System Medical Center page

7 registered trials is a research-attention snapshot, not an endorsement of Riverside University Health System Medical Center or any single study.

  • 2 of Riverside University Health System Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Vancomycin Resistant Enterococci Infection is the condition Riverside University Health System Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Vancomycin Resistant Enterococci Infection trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Riverside University Health System Medical Center pipeline card: 7 registered trials from official public datasets.Report a data error.